Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
91
Relative Risk01:12

Relative Risk

122
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
122
Hazard Rate01:11

Hazard Rate

91
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
91
Cancer Survival Analysis01:21

Cancer Survival Analysis

328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

99
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
99
Actuarial Approach01:20

Actuarial Approach

63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Future worldwide coronavirus disease 2019 epidemic predictions by Gaidai multivariate risk evaluation method.

Analytical science advances·2024
Same author

Gaidai reliability method for long-term coronavirus modelling.

F1000Research·2023
Same author

Prediction of death rates for cardiovascular diseases and cancers.

Cancer innovation·2023
Same author

Carbon Storage Tanker Lifetime Assessment.

Global challenges (Hoboken, NJ)·2023
Same author

Meta-Structure Hull Design with Periodic Layered Phononic Crystals Theory for Wide-Band Low-Frequency Sound Insolation.

Materials (Basel, Switzerland)·2023
Same author

Multi-regional COVID-19 epidemic forecast in Sweden.

Digital health·2023

Related Experiment Video

Updated: Jun 10, 2025

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.3K

HIV deathrate prediction by Gaidai multivariate risks assessment method.

Oleg Gaidai1

  • 1Department of Mechanics and Mathematics, Ivan Franko Lviv State University, Lviv, Ukraine.

Immunity, Inflammation and Disease
|October 16, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a new bio-statistical method to assess human immunodeficiency virus (HIV) mortality risks globally. The approach provides reliable, long-term HIV death rate assessments for public health planning.

Keywords:
AIAIDSHIVedidemic outbreakmathematical biologypublic‐health

More Related Videos

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

11.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Related Experiment Videos

Last Updated: Jun 10, 2025

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
07:06

Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach

Published on: December 1, 2011

13.3K
Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

11.1K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Area of Science:

  • Public Health
  • Biostatistics
  • Epidemiology

Background:

  • Human immunodeficiency virus (HIV) presents a significant global public health challenge due to its high transmissibility and mortality.
  • Existing methods for assessing HIV death risks often struggle with complex, high-dimensional multinational datasets.

Purpose of the Study:

  • To develop and apply a novel multivariate bio-risk assessment approach for determining excessive HIV death risks.
  • To enable reliable long-term HIV mortality assessments across diverse regions.

Main Methods:

  • A new population-based, multicenter, medical survey-based bio-statistical approach was developed.
  • The study applied the novel Gaidai method to raw, unfiltered clinical datasets, addressing challenges in bivariate and high-dimensional extreme value statistics.

Main Results:

  • The novel bio-risk assessment approach was successfully applied.
  • Reliable long-term HIV mortality risk assessments were achieved.

Conclusions:

  • The proposed methodology offers a robust tool for public health and clinical applications.
  • This approach can utilize available raw patient survey datasets for improved risk assessment.